CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for CH Boehringer Sohn AG & Co KG is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

CH Boehringer Sohn AG & Co KG
Binger Strasse 173
Phone: +49 6132770p:+49 6132770 Ingelheim am Rhein, 55216  Germany Fax: +49 6132773000f:+49 6132773000
Business Summary
CH Boehringer Sohn AG & Co KG is a Germany-based company that deals in the pharmaceutical sector and operates three business segments: Human Pharmaceuticals; Biopharmaceuticals, and Animal Health. The Human Pharmaceuticals business segment focuses on the development and production of pharmaceutical products mainly in the field of oncology, diabetes, asthma, and hepatitis C. The Biopharmaceuticals business segment consists of contract manufacturing business, biosimilars, and research and development of new biological active ingredients. The Animal Health business segment focuses on the development and manufactures of animal vaccines and other animal health products, including nutritional supplements and anti-inflammatory drugs.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202212/31/2022Yes----

Industries
SIC Code Description
8742 Management consulting services

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board of Managing Directors HubertusVon Baumbach 1/1/2020
Member of the Board of Managing Directors PaolaCasarosa 50
Member of the Board of Managing Directors ShashankDeshpande 51
Member of the Board of Managing Directors CarinneKnoche - Brouillon 58
Member of the Board of Managing Directors MichaelSchmelmer 59

Subsidiaries
Business Name Address City State/Province Country
T3 Pharmaceuticals AG Hegenheimermattweg 167A Allschwil Switzerland
Mosaic Biomedicals SL Edifici Cellex Barcelona Spain
Boehringer Ingelheim International GmbH Binger Straße 173 Ingelheim Germany
11 additional Subsidiary records available in full report.

Business Names
Business Name
BEN VENUE
Ben Venue Laboratories, Inc.
Bidachem S.p.A.
65 additional Business Names available in full report.

General Information
Number of Employees: 53,155 (As of 12/31/2022)
Fax Number: +49 6132773000


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024